+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases



Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases



Annals of Clinical Psychiatry 14(1): 59-64



Case reports and small retrospective studies suggest that atypical antipsychotic agents may be associated with new-onset Type II diabetes mellitus (DM) or diabetic ketoacidosis (DKA); however, these reports often provide limited or no information on demographic variables such as age, gender, ethnicity, relationship to weight gain, and time course. We analyzed 45 published cases of new-onset DM or DKA for which followed initiation of atypical antipsychotic treatment. Of the 45 patients, 20 had received clozapine, 19 olanzapine, 3 quetiapine, and 3 risperidone. Eighty-seven percent patients were male, and 47% African American. Forty-two percent of these patients presented as DKA, and 50% manifested no weight gain at time of presentation with DM or DKA, although 84% were overweight before antipsychotic therapy. Eighty-four percent presented within 6 months and 59% within 3 months of commencing atypical antipsychotics. The DKA cohort had significantly younger age, less overweight at baseline, and higher proportion of women than did those with DM alone, without significant differences in distribution of ethnicity, weight gain, family history of DM, or duration of exposure to atypical agents. Clinicians should be aware of the potential risks of new-onset DM and DKA in patients taking atypical antipsychotics, and utilize appropriate clinical and laboratory monitoring to prevent serious adverse events.

(PDF emailed within 0-6 h: $19.90)

Accession: 046973516

Download citation: RISBibTeXText

PMID: 12046641

DOI: 10.1023/a:1015228112495


Related references

Phenomenology of and Risk Factors for New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Atypical Antipsychotics: An Analysis of 45 Published Cases. Annals of Clinical Psychiatry 14(1): 59-64, 2002

Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. Clinical Pediatrics 42(7): 591-597, 2003

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. Journal of Clinical Psychiatry 68(4): 533-541, 2007

New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophrenia Research 59(1): 1-6, 1 January, 2003

New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophrenia Research 59(1): 1-6, 2002

Frequency and associated risk factors of recurrent diabetic ketoacidosis among Saudi adolescents with type 1 diabetes mellitus. Saudi Medical Journal 36(2): 216-220, 2015

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry 37(1): 1-11, 2004

Severe hypoglycemia and diabetic ketoacidosis in young persons with preschool onset of type 1 diabetes mellitus: An analysis of three nationwide population-based surveys. Pediatric Diabetes 19(4): 713-720, 2018

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 40(5): 438-443, 1999

Risk factors and predictors of uncontrolled hyperglycemia and diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus in Jeddah, western Saudi Arabia. Journal of Diabetes 9(2): 190-199, 2016

Varying degree of risks of developing new onset diabetes mellitus in patients treated with atypical antipsychotics. European Neuropsychopharmacology 13(Suppl. 4): S300-S301, 2003

New-onset diabetes mellitus presenting with diabetic ketoacidosis after pediatric liver transplantation. Pediatric Transplantation 13(5): 536-539, 2009

Lipemic serum in a toddler with new-onset diabetes mellitus presenting with diabetic ketoacidosis. Jop 13(1): 73-75, 2012

Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus. Clinical Pediatrics 56(2): 117-122, 2017

Acute post-operative diabetic ketoacidosis: Atypical harbinger unmasking latent diabetes mellitus. Indian Journal of Anaesthesia 60(10): 763-765, 2016